The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease
Open accessAbstract
Paget disease is the most exaggerated example of abnormal bone remodeling, with the primary cellular abnormality in the osteoclast. Mutations in the p62 (sequestosome 1) gene occur in one-third of patients with familial Paget disease and in a minority of patients with sporadic Paget disease, with the P392L amino acid substitution being the most commonly observed mutation. However, it is unknown how p62(P392L) mutation contributes to the development of this disease. To determine the effects of p62(P392L) expression on osteoclasts in vitro and in vivo, we introduced either the p62(P392L) or WT p62 gene into normal osteoclast precursors and targeted p62(P392L) expression to the osteoclast lineage in transgenic mice. p62(P392L)-transduced osteoclast precursors were hyperresponsive to receptor activator of NF-kappaB ligand (RANKL) and TNF-alpha and showed increased NF-kappaB signaling but did not demonstrate increased 1,25-(OH)(2)D(3) responsivity, TAF(II)-17 expression, or nuclear number per osteoclast. Mice expressing p62(P392L) developed increased osteoclast numbers and progressive bone loss, but osteoblast numbers were not coordinately increased, as is seen in Paget disease. These results indicate that p62(P392L) expression on osteoclasts is not sufficient to induce the full pagetic phenotype but suggest that p62 mutations cause a predisposition to the development of Paget disease by increasing the sensitivity of osteoclast precursors to osteoclastogenic cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, overexpression of SQSTM1 variants carrying disease-associated mutations in the UBA domain exhibit a PDB-like skeletal disorder [138,139] as well as impaired spatial learning and long-term memory [140].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Laurin, N., Brown, J. P., Morissette, J., & Raymond, V. (2002) · The American Journal of Human Genetics · doi:10.1086/340731 · Cited by 563 · cited 1×
“Both genetic and environmental factors have been proposed as contributing to the etiology of PD, and multiple families with an autosomal dominant mode of inheritance have been described (7, 8).”
BackgroundThe atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway
Sanz, L., Diaz‐Meco, M. T., Nakano, H., & Moscat, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 448
The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation
Sanz, L., Sánchez‐Gómez, P., Lallena, M., Díaz-Meco, M. T., & Moscat, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease.
Hocking, L. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2735 · Cited by 350
Durán, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., Moscat, J., & Diaz-Meco, M. T. (2004) · Developmental Cell · doi:10.1016/s1534-5807(03)00403-9 · Cited by 316
Kurihara, N., Chenu, C., MILLER, M., Civin, C. I., & Roodman, G. D. (1990) · Endocrinology · doi:10.1210/endo-126-5-2733 · Cited by 227
Self-citationLiu, B., Yu, S., & Li, T. (2003) · Journal of Oral Pathology and Medicine · doi:10.1034/j.1600-0714.2003.00126.x · Cited by 214
Siris, E. S. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.7.1061 · Cited by 168
Manipulating the mouse embryo a laboratory manual
Nagy, A. (2003) · Cited by 143
Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype
Kurihara, N., Reddy, S. V., Menaa, C., Anderson, D., & Roodman, G. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8489 · Cited by 141
Self-citationLoss of Ubiquitin-Binding Associated With Paget's Disease of Bone p62 (SQSTM1) Mutations
Cavey, J. R., Ralston, S. H., Hocking, L. J., Sheppard, P. W., Ciani, B., Searle, M. S., & Layfield, R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041205 · Cited by 120
Long-term trends in the incidence of Paget’s disease of bone
Tiegs, R. D., Lohse, C. M., Wollan, P. C., & Melton, L. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00333-1 · Cited by 120
Kurihara, N., Civin, C. I., & Roodman, G. D. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060307 · Cited by 116
Self-citationNeale, S. D., Smith, R., Wass, J. A. H., & Athanasou, N. A. (2000) · Bone · doi:10.1016/s8756-3282(00)00345-8 · Cited by 111
Three novel mutations in SQSTM1 identified in familial Paget’s disease of bone.
Johnson-Pais, T. L., Wisdom, J. H., Weldon, K. S., Cody, J. D., Hansen, M. F., Singer, F. R., & Leach, R. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.10.1748 · Cited by 110
Self-citationKurihara, N., Zhou, H., Reddy, S. V., Palacios, V. G., Subler, M. A., Dempster, D. W., Windle, J. J., & Roodman, G. D. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051108 · Cited by 104
Self-citationMenaa, C., Bársony, J., Reddy, S. V., Cornish, J., Cundy, T., & Roodman, G. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.2.228 · Cited by 98
Self-citationAtypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.
Kukita, A., Chenu, C., McManus, L. M., Mundy, G. R., & Roodman, G. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114565 · Cited by 87
Self-citationCharacterization of the mouse tartrate-resistant acid phosphatase (trap) gene promoter
Reddy, S. V., Hundley, J. E., Windle, J. J., Alcantara, O., Linn, R. A., Leach, R. J., Boldt, D. H., & Roodman, G. D. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100413 · Cited by 85
Self-citation(2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.12.2293 · Cited by 64
Ishizuka, S., Kurihara, N., Reddy, S. V., Cornish, J., Cundy, T., & Roodman, G. D. (2004) · Endocrinology · doi:10.1210/en.2004-1140 · Cited by 55
Self-citationRole of TAFII-17, a VDR Binding Protein, in the Increased Osteoclast Formation in Paget's Disease
Kurihara, N., Reddy, S. V., Araki, N., Ishizuka, S., Ozono, K., Cornish, J., Cundy, T., Singer, F. R., & Roodman, G. D. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040312 · Cited by 54
Self-citationFalchetti, A., Stefano, M. D., Marini, F., Monte, F. D., Gozzini, A., Masi, L., Tanini, A., Amedei, A., Carossino, A., Isaia, G., et al. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1828 · Cited by 19
In Memoriam Tribute to Jack W Coburn, MD: 1932–2004
Singer, F. R. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2004.19.12.2089 · Cited by 2
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 2000, J. Bone Miner. Res., 15, 2293
Cited by
Sorted by citations
Selective autophagy mediated by autophagic adapter proteins
Johansen, T., & Lamark, T. (2011) · Autophagy · doi:10.4161/auto.7.3.14487 · Cited by 1,788
p62 at the crossroads of autophagy, apoptosis, and cancer
Moscat, J., & Diaz-Meco, M. T. (2009) · Cell · doi:10.1016/j.cell.2009.05.023 · Cited by 1,073
<emph type="ital">SQSTM1</emph> Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Fecto, F. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.250 · Cited by 650
The Osteoclast: Friend or Foe?
Novack, D. V., & Teitelbaum, S. L. (2007) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151431 · Cited by 402
Roodman, G. D., & Windle, J. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24281 · Cited by 340
Self-citation
Metadata
- Authors
- Kurihara, N., Hiruma, Y., Zhou, H., Subler, M. A., Dempster, D. W., Singer, F. R., Reddy, S. V., Gruber, H. E., Windle, J. J., & Roodman, G. D.
- Affiliations
- VA Pittsburgh Healthcare System (US)
- University of Pittsburgh (US)
- Virginia Commonwealth University (US)
- Columbia University (US)
- Medical University of South Carolina (US)
- Carolinas Medical Center (US)
- Corresponding author
- Kurihara, Noriyoshi
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-01-02
- Volume
- 117
- Issue
- 1
- Pages
- 133-142
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1705822
- OpenAlex
- W2116217447
- Cited by
- 127
- References
- 25
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 9 · 2013: 8 · 2012: 7
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- National Institutes of Health (UL1TR000005, CA16059)
- VA Pittsburgh Healthcare System
- National Cancer Institute (P30CA16059, P30CA016059)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P01AR049363)
- National Center for Advancing Translational Sciences
- Medical Research and Materiel Command
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- p62, Paget disease, osteoclastogenesis, osteoclasts, bone remodeling, RANKL, NF-κB signaling, TNF-α, 1,25-dihydroxyvitamin D3, transgenic mice, bone loss, osteoclast precursors
- MeSH terms
- Sequestosome-1 Protein, Calcitriol, Cell Division, Humans, Mutation, Osteitis Deformans, Osteoclasts, Proteins, Tumor Necrosis Factor-alpha, Gene Transfer Techniques, Genetic Predisposition to Disease, Adaptor Proteins, Signal Transducing, RANK Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
